Paula Trefiak was one of the first ALS patients to take the drug tofersen as part of a clinical trial. Her experience shows ...

A Regina mother who was one of the first ALS patients to test a new treatment is now celebrating its accelerated approval in Canada for adults with an ultra-rare form of the disease.

At least $65 million slated for 14 of 35 Alzheimer's disease research centers is in limbo, with funding expected to run out ...

Damaged muscles in ALS patients release proteins previously linked only to brain disease In a nutshell Researchers discovered ...

The hurt of misdiagnosis was compounded by having "nowhere to voice my anger" or distress. Some of the most moving stories ...

As global populations age, neurological disorders such as Alzheimer's, Parkinson's, and epilepsy become more prevalent.

Recent studies have highlighted a link between amyotrophic lateral sclerosis (ALS) and gut microbiota. This prospective study aimed to evaluate the effects of electroacupuncture combined with Chinese ...

Scientists used positron emission tomography (PET) with edaravone, a drug used to treat ALS, to detect oxidative stress, which leads to brain damage, offering a clear path to detecting neurological ...

ALS, which is also known as Lou Gehrig's Disease, is a rare neurological disease that affects motor neurons — the nerve cells ...

Experts warn that difficulty swallowing, producing excess saliva or even drooling could be a sign of motor neurone disease ...